medigraphic.com
Boletín Médico del Hospital Infantil de México

2010, Number 5

<< Back Next >>

Bol Med Hosp Infant Mex 2010; 67 (5)

Integral approach of consumption and drug administration in a Mexican pediatric population

Jasso-Gutiérrez L

Language: Spanish
References: 55
Page: 399-415
PDF size: 322.84 Kb.


ABSTRACT

Background. In the absence of a comprehensive analysis of the pediatric age population, a classification is proposed that analyzes the use or administration of drugs in three stages: (1) intrauterine; (2) newborn to school-age and (3) adolescence, with special emphasis on the Mexican population.
Methods. Information was searched for in Medline, PubMed, EMBASE, INBIOMED, LILACS, and ARTEMISA.
Results. Stage 1 describes the effects of maternal drugs on the fetus such as fetal death, withdrawal syndrome, prematurity, and learning disorders. Stage 2 reports the damage due to the administration by the parents of over-the-counter (OTC) medications such as opioids, dextromethorphan, or psychostimulants. Stage 3 emphasizes that drug use among adolescents has increased in recent years and is accentuated in older ages. In 2008 it was reported as 5.7%, with marijuana, cocaine, inhalants and heroin being dominant.
Conclusions. We propose to conduct a national survey in Mexico that includes the three stages, extending the investigation of stage 3 by 7 years to 21 years. Simultaneously, a national outreach and educational program should be established, enabling an intelligent and permanent impact on the population as a whole.


REFERENCES

  1. Instituto Mexicano de Psiquiatría y Secretaría de Educación Pública. El consumo de drogas en México: Diagnóstico, Tendencias y Acciones. Disponible en: http://www.salud.gob.mx/unidades/cdi/documentos/CDM.htm#pres

  2. Substance Abuse and Mental Health Administration. Results from the 2006 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-32, DHHS, Publication No. SMA 07-4293, Rockville, MD, 2007

  3. McGlade A, Ware R, Crawford M. Child protection outcomes for infants of substance-using mothers: a matched-cohort study. Pediatrics 2009;124:285-293.

  4. Estrategia Nacional para el Control de las Drogas: 1997. II. Perfil del Abuso de drogas en los Estados Unidos. Disponible en: http://www.ncjrs.gov/htm/indice.htm.

  5. National Institute on Drug Abuse. Research Report Series–Marijuana Abuse. Updated 11/2/06.

  6. Jasso GL. Síndrome de Abstinencia. En: Jasso GL. Neonatología Práctica. México: El Manual Moderno, 2008. pp. 195-196.

  7. Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 2006;118:1149-1156.

  8. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. Philadelphia, PA: Lippincott Williams and Wilkins, 2005.

  9. American College of Obstetricians and Gynecologists (ACOG). Your Pregnancy and Birth. Washington, DC: ACOG, 2005.

  10. Bateman DA, Chiriboga CA. Dose-response effect of cocaine on newborn head circumference. Pediatrics 2000;106:E33.

  11. Vidaeff AC, Mastrobattista JM. In utero cocaine exposure: a thorny mix of science and mythology. Am J Perinatol 2003;20:165-172.

  12. Bauer CR, Langer JC, Shankaran S, Bada HS, Lester B, Wright LL, et al. Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med 2005;159:824-834.

  13. Fares I, McCulloch KM, Raju TN. Intrauterine cocaine exposure and the risk for sudden infant death syndrome: a meta-analysis. J Perinatol 1997;17:179-182.

  14. Singer LT, Minnes S, Short E, Arendt R, Farkas K, Lewis B, et al. Cognitive outcomes of preschool children with prenatal cocaine exposure. JAMA 2004;291:2448-2456.

  15. Linares TJ, Singer LT, Kirchner HL, Short E, Min MO, Hussey P, et al. Mental health outcomes of cocaine-exposed children at 6 years of age. J Pediatr Psychol 2006;31:85-97.

  16. Covington CY, Nordstrom-Klee B, Ager J, Sokol R, Delaney-Black V. Birth to age 7 growth of children prenatally exposed to drugs: a prospective cohort study. Neurotoxicol Teratol 2002;24:489-496.

  17. Levine TP, Liu J, Das A, Lester B, Lagasse L, Shankaran S, et al. Effects of prenatal cocaine exposure on special education in school-aged children. Pediatrics 2008;122:e83-e91.

  18. Salisbury AL, Ponder KL, Padbury JF, Lester BM. Fetal effects of psychoactive drugs. Clin Perinatol 2009;36:595-619.

  19. Belik J. Fetal and neonatal effects of maternal drug treatment for depression. Semin Perinatol 2008;32:350-354.

  20. O’Donnell M, Nassar N, Leonard H, Hagan R, Mathews R, Patterson Y, et al. Increasing prevalence of neonatal withdrawal syndrome: population study of maternal factors and child protection involvement. Pediatrics 2009;123:e614-e621.

  21. Cornelius MD, Day NL. Developmental consequences of prenatal tobacco exposure. Curr Opin Neurol 2009;22:121-125.

  22. Zammit S, Thomas K, Thompson A, Horwood J, Menezes P, Gunnell D, et al. Maternal tobacco, cannabis and alcohol use during pregnancy and risk of adolescent psychotic symptoms in offspring. Br J Psychiatry 2009;195:294-300.

  23. Rivkin MJ, Davis PE, Lemaster JL, Cabral HJ, Warfield SK, Mulkern RV. Volumetric MRI study of brain in children with intrauterine exposure to cocaine, alcohol, tobacco, and marijuana. Pediatrics 2008;121:741-750.

  24. Elliott EJ, Payne J, Morris A, Haan E, Bower C. Fetal alcohol syndrome: a prospective national surveillance study. Arch Dis Child 2008;93:732-737.

  25. Berenzon S, Romero M, Tiburcio M, Medina-Mora ME, Rojas E. Riesgos asociados al consumo de alcohol durante el embarazo en mujeres alcohólicas de la Ciudad de México. Salud Mental 2007;30:31-38.

  26. Ford JA. Misuse of over-the-counter cough or cold medications among adolescents: prevalence and correlates in a national sample. J Adolesc Health 2009; 44:505-507.

  27. Levine DA. “Pharming”: the abuse of prescription and over-the-counter drugs in teens. Curr Opin Pediatr 2007;19:270-274.

  28. Montgomery EJ, Wasserman GS. Toxicity and use of over-the-counter cough and cold medication in the pediatric population. Mo Med 2008;105:514-517.

  29. Ryan T, Brewer M, Small L. Over-the-counter cough and cold medication use in young children. Pediatr Nurs 2008;34:174-180.

  30. Lokker N, Sanders L, Perrin EM, Kumar D, Finkle J, Franco V, et al. Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. Pediatrics 2009;123:1464-1471.

  31. Crouch BI, Caravati EM, Booth J. Trends in child and teen nonprescription drug abuse reported to a regional poison control center. Am J Health Syst Pharm 2004;61:1252-1257.

  32. Bailey JE, Campagna E, Dart RC; RADARS System Poison Center Investigators. The underrecognized toll of prescription opioid abuse on young children. Ann Emerg Med 2009; 53:419-424.

  33. Mosholder AD, Gelperin K, Hammad TA, Phelan K, Johann-Liang R. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children. Pediatrics 2009;123:611-616.

  34. Encuesta nacional de adicciones 1998. 3. Encuestas en la población estudiantil. Disponible en: http://www.salud.gob.mx/unidades/cdi/documentos/CDM1-2.htm

  35. Villatoro VJA, Gutiérrez LML, Quiroz del Valle N, Moreno LM, Gaytán LL, Gaytán FFI, et al. Encuesta de estudiantes de la Ciudad de México 2006. Prevalencias y evolución del consumo de drogas. Salud Mental 2009;32:287-297.

  36. Ortiz A, Martínez R, Meza D. Sistema de reporte de información en drogas. Tendencias en el área metropolitana. Periodo 2006-2008. Disponible en: http://www.inprf.org.mx/avisos/srid/Principal.htlm

  37. Ortiz A, Martínez R, Meza D. Grupo Interinstitucional para el desarrollo del Sistema de Reporte de Información en Drogas. Resultados de la Aplicación de la Cédula: “Informe Individual sobre Consumo de Drogas”. Tendencias en el área metropolitana No. 40. Ed. Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. Noviembre del 2006.

  38. Ortiz A, Martínez R, Meza D. Grupo Interinstitucional para el desarrollo del Sistema de Reporte de Información en Drogas. Resultados de la Aplicación de la Cédula: “Informe Individual sobre Consumo de Drogas”. Tendencias en el área metropolitana No. 45. Ed. Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. Noviembre del 2008.

  39. Velázquez LM, Arellano PM. Consumo de drogas del niño en la calle. Consideraciones sobre su prevención y tratamiento. Programa Ollín. Arch Invest Pediátr Méx 2000;3:35-40.

  40. El consumo de drogas en México. Diagnóstico, tendencias y acciones. Estudio en poblaciones especiales de difícil acceso o de alto riesgo, 1998. Disponible en: http://www.salud.gob.mx/unidades/cdi/documentos/CDM1-5.htm

  41. Medina-Mora ME, Gutiérrez R, and Vega L. What happened to street kids? An analysis of the Mexican experience. Subst Use Misuse 1997;32:293-316.

  42. Secretaría de Salud. Encuesta Nacional de Adicciones 2008. Primera Edición 2008. Disponible en: http://www.conadic.salud.gob.mx/pdfs/ena08/ENA08_NACIONAL.pdf

  43. García Campos ML, Ferriani MG. Drugs use by six to seven-year-old children from an elementary school in Celaya, Guanajuato, México. Rev Lat Am Enfermagem 2008;16(Spec No):523-528.

  44. Wagner FA, Velasco-Mondragón HE, Herrera-Vázquez M, Borges G, Lazcano-Ponce E. Early alcohol or tobacco onset and transition to other drug use among students in the state of Morelos, Mexico. Drug Alcohol Depend 2005;77:93-96.

  45. Latimer W, Floyd LJ, Kariis T, Novotna G, Exnerova P, O’Brien M. Peer and sibling substance use: predictors of substance use among adolescents in Mexico. Rev Panam Salud Publica 2004;15:225-232.

  46. Rodríguez GM, Luis MA. Descriptive study of drug use among adolescents in higher middle education in Monterrey, Nuevo León, Mexico. Rev Lat Am Enfermagem 2004;12(Spec No):391-397.

  47. Benjet C, Borges G, Medina-Mora ME, Fleiz C, Blanco J, Zambrano J, et al. Prevalence and socio-demographic correlates of drug use among adolescents: results from the Mexican Adolescent Mental Health Survey. Addiction 2007;102:1261-1268.

  48. Medina-Mora ME, Borges G, Fleiz C, Benjet C, Rojas E, Zambrano J, et al. Prevalence and correlates of drug use disorders in Mexico. Rev Panam Salud Publica 2006;19:265-276.

  49. Medina-Mora ME, Peña-Corona MP, Cravioto P, Villatoro J, Kuri P. Del tabaco al uso de otras drogas: ¿el uso temprano de tabaco aumenta la probabilidad de usar otras drogas? Salud Publica Méx 2002;44(suppl 1):S109-S115.

  50. Latimer W, O’Brien M, Vásquez MA, Medina-Mora ME, Ríos CF, Floyd L. Adolescent substance abuse in Mexico, Puerto Rico and the United States: effect of anonymous versus confidential survey format. J Child Adolesc Subst Abuse 2006;16:69-89.

  51. Villatoro J, Medina-Mora ME, Gutiérrez ML, Fleiz C, Amador N, Quiroz N, Juárez F. Drug use among 7th-9th grade students in Baja California and Sonora and general population trends in drug use in Tijuana and Ciudad Juarez: 1998-2005. In: Border Epidemiology Work Group, eds. Border Epidemiology Work Group. Proceedings of the Border Epidemiology Work Group September 2006. Bethesda, Maryland: NIDA, 2006. pp. 12-16.

  52. Villatoro J, Medina-Mora ME, Gutiérrez ML, Fleiz C, and Amador N. Drug use and risky sexual behaviors among Mexican school students. In: Border Epidemiology Work Group, eds. Border Epidemiology Work Group. Proceedings of the Border Epidemiology Work Group September 2005. Bethesda, Maryland: NIDA, 2006. pp. 14-16.

  53. Lara MA, Medina-Mora,ME. Romero M, Domínguez M. Un estudio cualitativo sobre el consumo de disolventes inhalables en estudiantes. Psiquiatría Pública 1998;10:399-407.

  54. Villatoro J, Medina-Mora MA, Rojano C, Fleiz C, Bermúdez P, Castro P, et al. ¿Ha cambiado el consumo de drogas de los estudiantes? Resultados de la encuesta de estudiantes. Medición otoño del 2000. Salud Mental 2002;25:43-54.

  55. Benjet C, Borges G, Medina-Mora ME, Blanco J, Zambrano J, Orozco R, et al. Drug use opportunities and the transition to drug use among adolescents from the Mexico City Metropolitan Area. Drug Alcohol Depend 2007;90:128-134.




2020     |     www.medigraphic.com